Articles de revues sur le sujet « Strophanthinum »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Strophanthinum ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Shah, Yatin. "Strophanthin – ein besonderes Herzglykosid." Zeitschrift für Komplementärmedizin 3, no. 02 (2011): 48–51. http://dx.doi.org/10.1055/s-0030-1270928.
Texte intégralSchmidramsi, H., B. Ostermayr, and J. v. Arnim. "Proving of g-strophanthin." British Homoeopathic journal 82, no. 4 (1993): 269. http://dx.doi.org/10.1016/s0007-0785(05)80679-9.
Texte intégralTsyvunin, V. V., S. Yu Shtrygol, D. V. Shtrygol, and D. P. Kavraiskyi. "Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study." Acta Medica Leopoliensia 27, no. 1-2 (2021): 63–69. http://dx.doi.org/10.25040/aml2021.01-02.063.
Texte intégralVilensky, L. "Strofantin and novazurol for heart disease." Kazan medical journal 20, no. 9 (2021): 990–91. http://dx.doi.org/10.17816/kazmj77072.
Texte intégralMcKenzie, A. G. "The rise and fall of strophanthin." International Congress Series 1242 (December 2002): 95–100. http://dx.doi.org/10.1016/s0531-5131(02)00729-x.
Texte intégralDadashyan, A. M. "Experience in the use of convallotoxin in circulatory failure." Kazan medical journal 43, no. 5 (2021): 52–53. http://dx.doi.org/10.17816/kazmj87787.
Texte intégralFrost, Jørgen, and Erik Warburg. "Clinical experiences concerning the effect of strophanthin." Acta Medica Scandinavica 130, S206 (2009): 132–44. http://dx.doi.org/10.1111/j.0954-6820.1948.tb12030.x.
Texte intégralIonova, E. O., I. A. Miroshkina, A. V. Sorokina, and S. A. Kryzhanovskii. "Comparative evaluation of echocardiographic and morphometric characteristics of the rat heart left ventricle." Pharmacokinetics and Pharmacodynamics, no. 1 (May 10, 2023): 41–44. http://dx.doi.org/10.37489/2587-7836-2023-1-41-44.
Texte intégralGrosa, Giorgio, Gianna Allegrone, and Erika Del Grosso. "LC–ESI-MS/MS characterization of strophanthin-K." Journal of Pharmaceutical and Biomedical Analysis 38, no. 1 (2005): 79–86. http://dx.doi.org/10.1016/j.jpba.2004.12.008.
Texte intégralMosyagin, Vladimir. "THE INFLUENCE OF ELECTROLYTES OF THE IONS AND THE INHIBITOR ON THE ACTIVITY OF TOTAL ATPASE OF ERYTHROCYTES OF BROILER CHICKENS." Research Results in Pharmacology 2, no. (2) (2016): 113–18. https://doi.org/10.18413/2313-8971-2016-2-2-113-118.
Texte intégralOlesin, A. I., I. V. Konstantinova, N. N. Tyuteleva, and V. S. Ivanov. "Clinical and prognostic significance of left ventricular dysfunction predictors in patients with ventricular ectopy and without structural heart disease." Fundamental and Clinical Medicine 8, no. 3 (2023): 53–67. http://dx.doi.org/10.23946/2500-0764-2023-8-3-53-67.
Texte intégralArnim, H. Schmidramsl; B. Ostermayr; J. v. "g-Strophanthin - Ergebnisse von 2 Arzneimittelprüfungen mit der 4. Dezimalpotenz." Allgemeine Homöopathische Zeitung 238, no. 03 (2007): 106–9. http://dx.doi.org/10.1055/s-2006-936451.
Texte intégralChekman, I. S., N. A. Gorchakova, V. V. Bratus', and I. S. Mudraya. "Combined inotropic effect of strophanthin and calcium on heart muscle." Bulletin of Experimental Biology and Medicine 99, no. 3 (1985): 317–20. http://dx.doi.org/10.1007/bf00799077.
Texte intégralGalenko-Yaroshevskii, P. A., S. M. Lemkina, and Ya V. Kostin. "Drug correction of impaired strophanthin tolerance during simulated cardiac decompensation." Bulletin of Experimental Biology and Medicine 117, no. 5 (1994): 483–86. http://dx.doi.org/10.1007/bf02444295.
Texte intégralBogus, Saida K., Pavel A. Galenko-Yaroshevsky, Konstantin F. Suzdalev, Galina V. Sukoyan, and Valery G. Abushkevich. "2-phenyl-1-(3-pyrrolidin-1-il-propyl)-1 H-indole hydrochloride (SS-68): Antiarrhythmic and cardioprotective activity and its molecular mechanisms of action (Part I)." Research Results in Pharmacology 4, no. 1 (2018): 130–55. http://dx.doi.org/10.3897/rrpharmacology.4.28592.
Texte intégralBogus, Saida K., Pavel A. Galenko-Yaroshevsky, Konstantin F. Suzdalev, Galina V. Sukoyan, and Valery G. Abushkevich. "2-phenyl-1-(3-pyrrolidin-1-il-propyl)-1 H-indole hydrochloride (SS-68): Antiarrhythmic and cardioprotective activity and its molecular mechanisms of action (Part I)." Research Results in Pharmacology 4, no. (2) (2018): 133–50. https://doi.org/10.3897/rrpharmacology.4.28592.
Texte intégralTawfik, Hoda, Alanna A. L. Fox, and Kurt Greeff. "Comparative studies of some semisynthetic K-strophanthins with natural cardiac glycosides." Biochemical Pharmacology 34, no. 14 (1985): 2541–47. http://dx.doi.org/10.1016/0006-2952(85)90540-4.
Texte intégralKarsanov, N. V., G. V. Sukoyan, D. R. Tatulashvili, V. N. Karsanov та L. D. Mamulashvili. "Difference between mechanisms of action ofβ-acetyldigoxin, strophanthin K, and ouabain". Bulletin of Experimental Biology and Medicine 113, № 2 (1992): 186–89. http://dx.doi.org/10.1007/bf00791495.
Texte intégralKrupin, Theodore, Lisa F. Rosenberg, Arnold L. Sandridge, Charles J. Bock, Adrienne Berman, and Jon M. Ruderman. "Effects of Topical K-Strophanthin on Aqueous Humor and Corneal Dynamics." Journal of Glaucoma 4, no. 5 (1995): 327???333. http://dx.doi.org/10.1097/00061198-199510000-00006.
Texte intégralOlesin, Alexander I., Irina V. Konstantinova, Natalia N. Tyuteleva, Julia S. Zueva, Vladimir S. Ivanov, and Anastasia V. Koziy. "POLYMORPHIC VENTRICULAR EXTRASYSTOLIA IN PATIENTS WITHOUT STRUCTURAL CHANGES IN THE HEART: CLINICAL AND PROGNOSTIC SIGNIFICANCE AND ASSESSMENT OF THE EFFECTIVENESS OF THE THERAPY (CLINICAL AND EXPERIMENTAL STUDY)." Complex Issues of Cardiovascular Diseases 14, no. 1 (2025): 180–90. https://doi.org/10.17802/2306-1278-2025-14-1-180-190.
Texte intégralZENG, YONG-CHUN, ZHENG-JUN JIN, and PEI-KUN GU. "Retinal Toxicity in Albino Rabbits Induced by Intravitreal Injection of Strophanthin-K." Journal of Ocular Pharmacology and Therapeutics 6, no. 1 (1990): 51–60. http://dx.doi.org/10.1089/jop.1990.6.51.
Texte intégralSobieva, Z. I., M. N. Karpova, and E. G. Kryzhanovskaya. "Effect of lithium compounds on cardiac arrhythmias induced by strophanthin in conscious rats." Bulletin of Experimental Biology and Medicine 99, no. 4 (1985): 410–13. http://dx.doi.org/10.1007/bf00842725.
Texte intégralKudryavtseva, N. P., V. I. Kachurets, and S. X. Nasibullina. "The use of strophanthin in the complex treatment of cardiovascular disorders in toxic diphtheria." Kazan medical journal 43, no. 3 (2021): 42–43. http://dx.doi.org/10.17816/kazmj83692.
Texte intégralÖSTLING, GUSTAF. "The Significance of the Speed of Injection for the Therapeutic Effect of K-Strophanthin." Acta Medica Scandinavica 129, no. 1 (2009): 77–80. http://dx.doi.org/10.1111/j.0954-6820.1947.tb09286.x.
Texte intégralGuang-tian, Yang, and S. Daum. "Wirkung von Strophanthin, Digoxin und Isoproterenol auf die Herzkontraktilität während Hypoxie und hyperkapnischer Azidose." Journal of Tongji Medical University 6, no. 4 (1986): 199–205. http://dx.doi.org/10.1007/bf02909745.
Texte intégralSergeev, P. V., P. A. Galenko-Yaroshevskii, S. M. Lemkina, and Ya V. Kostin. "Comparative evaluation of pharmacological effects of combined application of strophanthin with some antiadrenergic agents." Bulletin of Experimental Biology and Medicine 119, no. 5 (1995): 484–87. http://dx.doi.org/10.1007/bf02543436.
Texte intégralPogorelova, V. N., A. I. Panait, and A. G. Pogorelov. "Nonspecific effect of Na+/K+-ATPase inhibition with strophanthin or under hypothermia in rat heart." Biophysics 59, no. 5 (2014): 768–71. http://dx.doi.org/10.1134/s0006350914050212.
Texte intégralRajabzoda, M. M. "Consequences of road transportation accidents, their standard growth, modern management and tactics of treatment of victims." Health care of Tajikistan, no. 2 (July 21, 2022): 82–87. http://dx.doi.org/10.52888/0514-2515-2022-353-2-83-88.
Texte intégralBauer, N., G. Scheiner-Bobis, and W. Schoner. "„Endogenes Digitalis” – der lange Weg vom herzwirksamen pflanzlichen Toxin zum Hormon der Säuger." Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere 34, no. 06 (2006): 389–97. http://dx.doi.org/10.1055/s-0037-1622553.
Texte intégralSørensen, Else Vigholt, and Folmer Nielsen-Kudsk. "Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart." European Journal of Pharmacology 125, no. 3 (1986): 363–71. http://dx.doi.org/10.1016/0014-2999(86)90792-2.
Texte intégralMikhailov, I. B. "Effect of strophanthin and digoxin on activity of an experimental epileptogenic focus in the frog hippocampus." Bulletin of Experimental Biology and Medicine 104, no. 5 (1987): 1572–74. http://dx.doi.org/10.1007/bf00845084.
Texte intégralRoshni, SS, Sneha Geevarghese, S. Sujith, Preethy John, R. Uma, and AR Nisha. "Evaluation of cytotoxic potential of leaves of Cyclea peltata in MCF-7 cell lines." Journal of Phytopharmacology 14, no. 2 (2025): 78–86. https://doi.org/10.31254/phyto.2025.14202.
Texte intégralFazulzyanov, A. A., V. M. Andreev, and G. N. Fazulzyanova. "Respiratory mechanics, alveolar ventilation, ventilation-perfusion relations in the correction of heart failure with strophanthin and kapoten." Kazan medical journal 76, no. 6 (1995): 417–19. http://dx.doi.org/10.17816/kazmj90429.
Texte intégralBonah, Christian. "‘The Strophanthin question’: early scientific marketing of cardiac drugs in two national markets (France and Germany, 1900–1930)." History and Technology 29, no. 2 (2013): 135–52. http://dx.doi.org/10.1080/07341512.2013.833039.
Texte intégralHassan, A. B., M. Atef, and I. M. Shihata. "Effect of Digoxin and Strophanthin on Renal Blood Flow and Systemic Blood Pressure in Normal and Bled Dogs." Zentralblatt für Veterinärmedizin Reihe A 26, no. 2 (2010): 152–58. http://dx.doi.org/10.1111/j.1439-0442.1979.tb00660.x.
Texte intégralGalenko-Yaroshevskii, P. A., S. M. Lemkina, and Ya V. Kostin. "Effects of the membrane stabilizer ajmaline and the local anesthetic trimecaine on the pharmacological effects of strophanthinin vivo andin vitro." Bulletin of Experimental Biology and Medicine 117, no. 1 (1994): 61–64. http://dx.doi.org/10.1007/bf02444082.
Texte intégralKarsanov, N. V., T. N. Macharashvili, and V. A. Magaldadze. "Action of strophanthin K and ?-acetyldigoxin in vitro on energy transformation by the contractile protein system of normal cardiomyocytes." Bulletin of Experimental Biology and Medicine 108, no. 6 (1989): 1735–38. http://dx.doi.org/10.1007/bf00841047.
Texte intégralGalenko-Yaroshevskii, P. A., S. M. Lernkina, and Ya V. Kostin. "Correction with cordarone of changes in cathepsin D activity induced by modeled circulation insufficiency and toxic action of strophanthin K." Bulletin of Experimental Biology and Medicine 122, no. 4 (1996): 1005–7. http://dx.doi.org/10.1007/bf02447021.
Texte intégralGalenko-Yaroshevskii, P. A., S. M. Lemkina та Ya V. Kostin. "Correction of altered β-glucosidase activity induced by the toxic effect of strophanthin K and modeled cardiac decompensation with cordaron". Bulletin of Experimental Biology and Medicine 121, № 6 (1996): 581–83. http://dx.doi.org/10.1007/bf02447123.
Texte intégralKarsanov, N. V., V. A. Magaldadze, and T. N. Macharashvili. "Action of strophanthin K and ?-acetyldigoxin in vitro on energy transformation by the myocardial contractile protein system in toxico-allergic cardiomyopathy." Bulletin of Experimental Biology and Medicine 111, no. 5 (1991): 698–700. http://dx.doi.org/10.1007/bf00841022.
Texte intégralAgostoni, Pier Giuseppe, Elisabetta Doria, Marco Berti, and Maurizio D. Guazzi. "Long-term use of K-strophanthin in advanced congestive heart failure due to dilated cardiomyopathy: A double-blind crossover evaluation versus digoxin." Clinical Cardiology 17, no. 10 (1994): 536–41. http://dx.doi.org/10.1002/clc.4960171005.
Texte intégralKrvavych, Anna, and Roksolana Konechna. "Optimization of parameters of the extraction process of biologically active substances of grass Adonis vernalis." Technology audit and production reserves 3, no. 3(59) (2021): 14–18. http://dx.doi.org/10.15587/2706-5448.2021.235471.
Texte intégralAnna, Krvavych, and Konechna Roksolana. "Optimization of parameters of the extraction process of biologically active substances of grass Adonis vernalis." Technology audit and production reserves 3, no. 3(59) (2021): 14–18. https://doi.org/10.15587/2706-5448.2021.235471.
Texte intégralGalust'yan, G. �., and I. B. Mikhailov. "Effect of strophanthin and digoxin on succinate and lactate dehydrogenase and membrane Na+, K+-ATPase activity in the heart of rats with experimental myocarditis." Bulletin of Experimental Biology and Medicine 107, no. 4 (1989): 498–500. http://dx.doi.org/10.1007/bf00842388.
Texte intégralDanielopolu, D., Marin Popescu, and Gr Gr Popa. "Action of Drugs on Cholinesterase and on the Adrenolytic Factors. Inactivating Action of Eserine, Strophanthin and Ascorbic Acid on Cholinesterase and on the Adrenolytic Factors." Acta Pharmacologica et Toxicologica 4, no. 3-4 (2009): 339–50. http://dx.doi.org/10.1111/j.1600-0773.1948.tb03356.x.
Texte intégralDatté, J. Y., and A. Ziegler. "Pharmacological investigation on nigrescigenin-a cardenolide fromParquetina nigrescens(Afzel.) Bullock: comparative studies on cardiotonic effects ofParquetina nigrescens, g-strophanthin and noradrenaline in guinea-pig isolated atria." Journal of Pharmacy and Pharmacology 53, no. 6 (2001): 859–66. http://dx.doi.org/10.1211/0022357011776018.
Texte intégralSugimoto, Jiro, Seiichi Yuasa, and Masayasu Suzuki. "Comparison of Effects of Alprenolol, Carteolol, Indenolol, Pindolol, Practolol, and Propranolol in Relation to their Beta-Blocking, Local Anaesthetic, Membrane Stabilizing, and Strophanthin-G Cardiotoxicity Antagonizing Actions in Guinea-Pig." Journal of Kansai Medical University 39, no. 4 (1987): 418–29. http://dx.doi.org/10.5361/jkmu1956.39.4_418.
Texte intégralDoepp, Manfred. "May Strophanthin be a valuable cardiac drug ?" American Journal of Medical and Clinical Research & Reviews 02, no. 09 (2023). http://dx.doi.org/10.58372/2835-6276.1069.
Texte intégral"Die Lösung des Herzinfarkt-Problems durch g-Strophanthin." Erfahrungsheilkunde 53, no. 02 (2004): 65–73. http://dx.doi.org/10.1055/s-2004-819994.
Texte intégralSharma, Ashish Kumar, Shivam Singh, Mehvish Bhat, et al. "New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models." Scientific Reports 13, no. 1 (2023). http://dx.doi.org/10.1038/s41598-023-41942-4.
Texte intégral